Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of the Omnipod® 5 SmartAdjust 2.0 System in Individuals With Type 1 and Type 2 Diabetes

NCT06547918 is registered in ClinicalTrials.gov with Insulet Corporation as lead sponsor.

NCT NCT06547918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06547918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of the Omnipod® 5 SmartAdjust 2.0 System in Individuals With Type 1 and Type 2 Diabetes
Lead sponsor
Insulet Corporation
Phase
Not applicable
Overall status
Completed
Start date
July 18, 2024
Completion date
September 8, 2025
Enrollment
48 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus